GM Kills $10 Million Facebook Ad Campaign Because It Didn't Work
PC Upgrades on Byte-Size Budgets -- Savings Experiment
MOST NOTEWORTHY: Notable upgrades today include Target (TGT) and Pfizer (PFE).
- Target Corp. (NYSE:TGT) was added to Goldman Sachs America's Conviction Buy List, citing expectations for strong holiday momentum to continue.
- Pfizer Inc. (NYSE:PFE) was upgraded to Neutral from Underperform at Cowen, based on additional evidence and conviction in cost savings, and a realistic and determined management team.
OTHER UPGRADES:
- J.C. Penney (NYSE:JCP) was added to Citigroup's Recommended List; The retailer holds a Buy rating with the company.
- Boeing Co. (NYSE:BA) was added to Merrill Lynch's Focus List with a $105 target, citing a higher delivery forecast for their commercial planes unit.
- Anheuser-Busch Inc. (NYSE:BUD) was upgraded to Neutral from Reduce at UBS, citing the company's long-term potential with InBev brands.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
